Middle East Pharmaceutical Industries Co.

4016 Healthcare Shariah
شركة الشرق الأوسط للصناعات الدوائية
116.30 SAR
+0.50 (+0.43%)
Live • 12:46
Open
115.50
High
116.70
Low
114.30
Volume
0.0M
52W High
140.60
52W Low
108.00
Market Cap
2.30B SAR
P/E Ratio
23.48
Dividend Yield
3.83%
Beta
N/A

Price Chart

455 trading days
Since Feb 2024

Technical Analysis

DOWNTREND
RSI (14)
38.1
Neutral
Volatility (20D)
27.65%
Support
114.50
Resistance
116.00

Moving Averages

SMA 20
120.07
SMA 50
126.47
SMA 200
125.30
MA: Bearish RSI: Neutral

About Middle East Pharmaceutical Industries Co.

Middle East Pharmaceutical Company Ltd. is a prominent entity in the pharmaceuticals sector, primarily involved in the manufacture and distribution of a wide range of healthcare products. Focused on addressing local and regional healthcare needs, the company delivers medicinal products that serve therapeutic areas such as cardiology, endocrinology, and oncology, among others. The company's operations are integral to the healthcare infrastructure in the Middle East, supporting both retail and institutional clients, including hospitals and clinics. By coupling rigorous research and development with strict adherence to regulatory standards, Middle East Pharmaceutical Company Ltd. ensures the availability of quality medicines. Its strategic presence in the Middle East medical market underscores its role in enhancing access to essential medicines and supporting public health initiatives.

Sector Healthcare
Employees 632
CEO Mr. Mohammed Maher MohammedLotfi Al-Ghannam
Website Visit

Performance

1 Day +0.43%
5 Days +0.09%
1 Month -6.74%
3 Months -6.66%
1 Year -0.60%
52-Week Range
108.00 140.60
25.5% of range

Key Statistics

As of 2025-12-21
Market Cap 2.30B SAR
P/E Ratio 23.48
Forward P/E 22.37
EPS (TTM) 4.86 SAR
Dividend Yield 3.83%
Beta N/A
Avg Volume 20,610

Latest News

No recent news for 4016